Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical calcipotriol for prevention of hypertrophic scars after reduction mammoplasty
NL-OMON27742Active, not recruiting
- Sponsor
- VU University Medical Center, Amsterdam. This investigation was supported by a grant of the Dutch Burns Foundation and the Cornelis Visser Foundation.
- Start
- Jan 2002
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of calcipotriol in Hypertrophic Scar (HS), sponsored by VU University Medical Center, Amsterdam. This investigation was supported by a grant of the Dutch Burns Foundation and the Cornelis Visser Foundation. Primary endpoints: Clinical scar status, Scar thickness by ultrasound and 1 more. Started Jan 2002; status: active, not recruiting.
02
Drugs
calcipotriol
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NL-OMON27742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27742.